Valuations may temper gains for GlaxoSmithKline Pharma despite strong Q1

Quick Summary:

Need More Information - write to us at assist@bsmail.

The recent gains were on account of a better-than-expected performance in the June quarter.

The stock of pharma major GlaxoSmithKline Pharmaceuticals (GSK Pharma) was up about 5.7 per cent to Rs 3,059, taking the gains since its results earlier this month to 11 per cent.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: GSK Pharma GlaxoSmithKline Pharmaceuticals Pharma sector

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-21 @ 20:34:27 (4 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 100 words

Reading Time: 1 minutes read

Sentences: 5 lines

Sentence Length: 20 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22196193

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 313 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions